News about Global Pharma

DHL Group Acquires CRYOPDP from Cryoport to Boost DHL Health Logistics

Going forward, DHL Supply Chain will further build the potential of its Pharma Specialized Network solution by leveraging the specialty courier expertise of newly acquired CRYOPDP and the global air capabilities of DHL Express and DHL Global Forwarding.

Global Pharma | 05/04/2025 | By Aishwarya |  364

Novartis Completes Acquisition of Anthos Therapeutics for Up to USD 3.1 Billion

Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialise abelacimab.

Global Pharma | 04/04/2025 | By Abha |  791

Sai Life Sciences Establishes Peptide Research Centre in Hyderabad

Sai Life Sciences has inaugurated a state-of-the-art Peptide Research Centre at its Hyderabad R&D campus, expanding its capabilities in complex peptide synthesis and conjugation to support next-generation therapeutics.

Global Pharma | 04/04/2025 | By Abha |  379

MJFF Selects ONTOFORCE DISQOVER to Enhance Integration and Access of PD Research

DISQOVER, ONTOFORCE’s advanced knowledge discovery platform, will support MJFF’s Targets to Therapies Initiative, a program aimed to expand the number of promising, druggable biological targets within the Parkinson’s disease (PD) translational pipeline.

Global Pharma | 04/04/2025 | By Aishwarya |  194

Entos Pharmaceuticals and Circio to Develop Novel Platform for CircVec Circular RNA Delivery

Under the collaboration, Entos will develop and validate PLV-formulations of Circio´s circVec DNA vectors and perform technical testing in vivo.

Global Pharma | 04/04/2025 | By Aishwarya |  348

Append Medical Appoints Shlomi Nachman as Chairman of the Board

Append Medical announce the appointment of Shlomi Nachman as Chairman of the Board. This strategic move reflects the company's commitment to advancing its mission of reducing stroke risks for patients with atrial fibrillation through groundbreaking technology.

Global Pharma | 03/04/2025 | By Manvi |  162

Gland Pharma Secures USFDA Approval for Acetaminophen Injection

Gland Pharma has received USFDA approval for its Acetaminophen Injection, a bioequivalent version of B. Braun Medical’s product, used for managing mild to moderate pain. The company plans to launch the product soon through its marketing partner.

Global Pharma | 03/04/2025 | By Manvi |  642

Novartis Gets FDA Accelerated Approval for Vanrafia

Vanrafia was granted accelerated approval based on a prespecified interim analysis of the Phase III ALIGN study measuring the reduction of proteinuria at 36 weeks compared to placebo1. It has not been established whether Vanrafia slows kidney function decline in patients with IgAN.

Global Pharma | 03/04/2025 | By Aishwarya |  411

Lupin Acquires Renascience to Expand its Footprint in United Kingdom

With this acquisition, Lupin Healthcare (UK) gains full ownership of Renascience which, going forward, will trade as its subsidiary.

Global Pharma | 03/04/2025 | By Aishwarya |  443

Syntegon Plans to Relocate and Expand Business Growth at New Sites

The activities of the Pharma Solid business unit located in Waiblingen will move to a dedicated pharma site in neighboring Fellbach in the second half of 2025.

Global Pharma | 03/04/2025 | By Aishwarya |  606